Knobbe/Martens: Intellectual Property Law
Developing IP strategies aimed at furthering my client’s business goals is my constant focus.

Kerry S. Taylor, Ph.D.

Partner

At a Glance

  • J.D. University of California - Berkeley School of Law
  • Ph.D. Biochemistry & Molecular Biology, University of Chicago
  • B.S. Chemistry, Wheaton College

  • State Bar of California
  • U.S. Patent and Trademark Office

Cases, Articles, Speeches & Seminars

Representative Matters

  • Complete Genomics, Inc. v. Illumina Cambridge Ltd., Case Nos. IPR2017-02172 and IPR2017-02174 (2018). Defended Illumina against petitions for IPR regarding a patent directed to DNA sequencing-by-synthesis.  Obtained decisions denying petitions and rejecting all challenges raised against Illumina’s claims.
  • Illumina, Inc. v. Cornell Research Foundation, Inc., Case IPR2016-00557 (2017). Represented Illumina in an IPR proceeding challenging a patent relating to assays for DNA detection. Achieved favorable case-dispositive settlement for client after institution of the IPR.
  • Intelligent Bio-Systems, Inc. v. Illumina Cambridge Ltd., 821 F.3d 1359 (Fed. Cir. 2016). Represented Illumina and obtained affirmance of IPR final written decision upholding the validity of all challenged claims from a patent directed to DNA sequencing-by-synthesis.
  • Ariosa Diagnostics, Inc. v. Illumina, Inc., Case IPR2014-01093 (2016). Represented Illumina in an IPR proceeding defending a patent directed to noninvasive prenatal screening methods.  Obtained final written decision upholding the validity of all challenged claims.
  • Roche Molecular Systems Inc. v. Illumina, Inc., Case IPR2015-01091 (2015). Defended Illumina against a petition for IPR regarding a patent for noninvasive prenatal screening methods.  Obtained decision denying petition and rejecting all challenges raised against Illumina’s claims.
  • Intelligent Bio-Systems, Inc. v. Illumina Cambridge Ltd., Case IPR2013-00517 (2015). Represented Illumina in an IPR proceeding defending a patent directed to DNA sequencing-by-synthesis.  Obtained final written decision upholding the validity of all challenged claims.
  • BioGatekeeper, Inc. v. Kyoto University, Case IPR2014-01286 (2015). Represented Kyoto University against a petition for IPR regarding a patent co-invented by Nobel Prize laureate Professor Shinya Yamanaka directed to induced pluripotent stem cells.  Obtained decision denying petition and rejecting the challenge raised against Kyoto University's patent.
  • Ranbaxy Labs., Ltd. and Ranbaxy, Inc. v. Vertex Pharms., Inc., Case IPR2013-00024 (2013). Represented Ranbaxy in an IPR proceeding challenging a patent relating to fosamprenavir (the active ingredient in Lexiva®).  Achieved favorable case-dispositive settlement for client after institution of the IPR.

Articles, Speeches & Seminars

Attorney Finder